Purchase Options

The development of smart insulin is accelerating the growth of healthcare and digital science leading to cures and treatments of patients with Type 1 and Type 2 diabetes by promoting upcoming approaches. Smart insulin works accordingly in response to blood glucose concentration; the higher the blood glucose more concentration of insulin is released and less insulin is released in response to lower blood glucose. The emergence of these healthcare-cum-technology have addressed the soaring need for better diagnostics as compared to current insulin supply since it reduces the diabetes related stress, decreases the need of regular blood tests, no other insulin supplement is required, prevents carb counting and smart insulin injection can be applied only once a day. Minimal weight gain and reduced risk of hypoglycemia are recent success that has opened new avenues for smart insulin usage.

The global smart insulin market is expected to register substantial growth in the near future, attributed to rising prevalence of diabetic patients, advancements in technological delivery devices, high demand for better efficacy products and replacement of painful injections with technology advancements. In addition, favorable government policies and increased collaborations among companies and research institutions are driving factors of market. However, high investment cost, more manufacturing complexities and stringent regulatory requirements for product approval are factors that can hinder the market growth. Growing personalized awareness and spreading of technology in emerging economies leads to prospering of this market.

The report segments the smart insulin market on the basis of types, diseases, delivery devices and geography. On the basis of types, market is diverged into rapid acting, intermediate acting, long acting, short acting and premixed type of insulin. Based on diseases, the market is segmented into Type 1 diabetes and Type 2 diabetes. The market segmentations on the basis of delivery devices are smart insulin pen, smart insulin pump and smart insulin patch or microneedle array patch. The market is analyzed across geographical regions namely North America, Europe, Asia-Pacific, and LAMEA.

Healthcare giants such as Juvenile Diabetes Research Foundation and SmartCells are collaborated in a partnership where SmartCells received $1 million fund for safety and efficacy studies for preclinical testing of smart insulin on animals. Furthermore, Juvenile Diabetes Research Foundation has introduced Glucose Responsive Insulin Grand Challenge Prize which draws the group of scientists to this innovative field.

Comprehensive competitive analysis and profiles of major market players such as Juvenile Diabetes Research Foundation Ltd, Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Merck & Co., Inc., and MannKind Corporation are provided in this report. Other companies undergoing the clinical trials are ADOCIA, Biodel Inc., Biocon and Halozyme, Inc. is also provided in this report.

KEY BENEFITS FOR STAKEHOLDERS:

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global smart insulin market.In-depth analysis has been done in this report by constructing market estimations for the key market segments between 2014 and 2022This study evaluating competitive landscape and value chain has been taken into account to help in understanding the competitive environment across the geographiesRegion-wise and country-wise global smart insulin market conditions are comprehensively analyzed in this report.Comprehensive analysis of all regions are provided that determines the prevailing opportunities in these geographiesAn in-depth analysis of current research and clinical developments within global smart insulin market is provided with key market dynamic factors that help in understanding the behaviour of the market

SMART INSULIN OR GLUCOSE RESPONSIVE INSULIN MARKET KEY SEGMENTS:

Market by Types

Rapid Acting

Intermediate Acting

Long Acting

Short Acting

Premixed Type

Market by Diseases

Type 1 Diabetes

Type 2 Diabetes

Market by Delivery Devices

Smart Insulin Pen

Smart Insulin Patch or Microneedle Array Patch

Smart Insulin Pump

Market byGeography

North America

U.S.

Canada

Mexico

Europe

U.K.

Germany

France

Others

Asia-Pacific

Japan

India

China

Others

LAMEA

Brazil

U.A.E

Africa

Others

Let us know more about your research need and we will customize an offer exclusively for you!

Name

*

Company Name

*

Job Role

*

Email

*

Country Name

*

Phone No

*

Message

*

Security Code

*

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR)
encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only
engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates
and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within
each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors
and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis
and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and
allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning

Technologically sophisticated and reliable insights through well audited and veracious research methodology

Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to:
Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.